Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
Acute pulmonary embolism is a frequent condition in emergency medicine and potentially fatal. Cause of death is right ventricular failure due to increased right ventricular afterload from both pulmonary vascular obstruction and vasoconstriction. Inodilators are interesting drugs of choice as they ma...
Saved in:
| Main Authors: | Mads D. Lyhne, Simone J. Dragsbaek, Jacob V. Hansen, Jacob G. Schultz, Asger Andersen, Jens Erik Nielsen‐Kudsk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-07-01
|
| Series: | Pulmonary Circulation |
| Subjects: | |
| Online Access: | https://doi.org/10.1177/20458940211022977 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
by: Veronica Gagliardi, et al.
Published: (2025-05-01) -
Pulmonary Artery Pulsatility Index in Acute and Chronic Pulmonary Embolism
by: Mads Dam Lyhne, et al.
Published: (2025-02-01) -
Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children
by: Prijić Sergej, et al.
Published: (2011-01-01) -
Effect of Levosimendan Use on All-Cause Mortality in Out-of-Hospital Cardiac Arrest Survivors After Extracorporeal Cardiopulmonary Resuscitation
by: Da-Long Chen, et al.
Published: (2025-04-01) -
Intravenous Levosimendan versus Inhalational Milrinone in the Management of Pulmonary Hypertension during Adult Cardiac Surgery: A Randomized Clinical Trial
by: Panagiotis Ftikos, et al.
Published: (2024-09-01)